This is a routine administrative filing with no trading signal. Monitor upcoming filings for updates on the ATH434 Phase 3 program or capital raise activities, which are the primary value drivers for this pre-revenue biotech.
Price Chart
Executive Summary
Alterity Therapeutics filed a Form 6-K on September 16, 2026, solely to submit an exhibit (Exhibit 99.1) regarding an application for quotation of securities (ATH). The filing contains no new financial data, operational updates, or material corporate events. It is a routine administrative filing related to the listing of securities, with no substantive impact on the company's valuation or outlook.
Key Facts
- Filed Form 6-K on September 16, 2026.
- Exhibit 99.1 is an application for quotation of securities (ATH).
- No financial results, guidance, or material operational updates were provided.
- The filing is incorporated by reference into existing S-8 and F-3 registration statements.
Financial Impact
No financial impact; routine securities quotation application.
Risk Factors
- No new information to assess risk; the company faces going-concern risk as noted in the prior 20-F filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-030495 |
| Document: 0001437749-26-030495-index-headers.html | 0001437749-26-030495 |
| Document: 0001437749-26-030495-index.html | 0001437749-26-030495 |
| Document: 0001437749-26-030495.txt | 0001437749-26-030495 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.14 (−2.39%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.14 (+2.39%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.14 (+2.39%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.14 (−10.46%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.14 (−10.46%) |
Oct 19, 2026 8d ago | 6-K | $2.43 | awaiting T+60 | — | $2.14 (−11.93%) |
Oct 9, 2026 18d ago | 6-K | $3.12 | awaiting T+60 | — | $2.14 (−31.41%) |
Oct 5, 2026 22d ago | Press Release | $3.22 | awaiting T+60 | — | $2.14 (−33.54%) |
Oct 5, 2026 22d ago | 6-K | $3.22 | awaiting T+60 | — | $2.14 (−33.54%) |
Sep 25, 2026 4w ago | 6-K | $3.67 | awaiting T+60 | — | $2.14 (−41.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers